Predicted to enable natural killer cell lectin-like receptor binding activity. Predicted to act upstream of or within negative regulation of osteoclast differentiation and protection from natural killer cell mediated cytotoxicity. Predicted to be located in cell surface and endoplasmic reticulum. Predicted to be active in external side of plasma membrane. Orthologous to human CLEC2D (C-type lectin domain family 2 member D). [provided by Alliance of Genome Resources, Apr 2022]